AMGEN INC is 99.7x more valuable than NOVAVAX INC by market capitalization ($183.41 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVAX | AMGN |
|---|---|---|
| Market cap | $1.84 B | $183.41 B |
| US-listed rank | #2165 | #79 |
| Revenue (latest FY) | $1.12B | $36.75B |
| Net income (latest FY) | $440.30M | $7.71B |
| Net margin | 39.2% | 21.0% |
| P/E (trailing FY) | 4.2 | 23.8 |
| SEC filings | 1,627 | 1,011 |
AMGEN INC is 99.7x more valuable than NOVAVAX INC by market capitalization ($183.41 B vs $1.84 B).
In their latest fiscal years, NOVAVAX INC reported $1.12B in revenue while AMGEN INC reported $36.75B.
Full pages: NOVAVAX INC and AMGEN INC, or browse the full rankings.